ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 169 filers reported holding ARIAD PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 1.46 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $3,157,000 | -19.2% | 253,807 | -11.1% | 0.01% | -25.0% |
Q3 2016 | $3,909,000 | +50.1% | 285,532 | -19.0% | 0.01% | +50.0% |
Q2 2016 | $2,605,000 | +7.7% | 352,467 | -6.9% | 0.01% | 0.0% |
Q1 2016 | $2,419,000 | -35.1% | 378,568 | -36.5% | 0.01% | -27.3% |
Q4 2015 | $3,728,000 | -15.3% | 596,448 | -20.9% | 0.01% | -21.4% |
Q3 2015 | $4,401,000 | -37.1% | 753,679 | -10.9% | 0.01% | -17.6% |
Q2 2015 | $6,993,000 | +19.1% | 845,615 | +18.7% | 0.02% | +21.4% |
Q1 2015 | $5,870,000 | +49.5% | 712,320 | +24.7% | 0.01% | +40.0% |
Q4 2014 | $3,926,000 | +30.0% | 571,443 | +2.2% | 0.01% | +42.9% |
Q3 2014 | $3,021,000 | -8.4% | 559,392 | +8.1% | 0.01% | -12.5% |
Q2 2014 | $3,297,000 | -39.6% | 517,570 | -23.6% | 0.01% | -50.0% |
Q1 2014 | $5,459,000 | +44.0% | 677,369 | +21.8% | 0.02% | +33.3% |
Q4 2013 | $3,792,000 | -43.0% | 556,030 | +53.8% | 0.01% | -50.0% |
Q3 2013 | $6,651,000 | +12.9% | 361,471 | +7.3% | 0.02% | -4.0% |
Q2 2013 | $5,890,000 | – | 336,767 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 12,000,000 | $96,720,000 | 33.30% |
Opaleye Management Inc. | 1,670,000 | $13,460,000 | 9.94% |
Slate Path Capital LP | 6,620,000 | $53,357,000 | 4.04% |
Granite Point Capital Management, L.P. | 648,000 | $5,223,000 | 3.74% |
Palo Alto Investors LP | 6,917,248 | $55,754,000 | 2.30% |
Camber Capital Management LP | 3,000,000 | $24,180,000 | 1.90% |
Geduld E E | 277,600 | $2,237,000 | 1.21% |
Elk Creek Partners, LLC | 290,886 | $2,345,000 | 1.01% |
SELZ CAPITAL LLC | 400,000 | $3,224,000 | 0.81% |
GENERAL AMERICAN INVESTORS CO INC | 1,200,000 | $9,672,000 | 0.81% |